Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH
04:05pm, Tuesday, 19'th May 2026
Thomas Dittrich Returning to Amgen as CFO THOUSAND OAKS, Calif., May 19, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the retirement of Peter Griffith, who has served as the company's exec
Amgen's rare disease drug linked to deaths, liver injuries in Japan, WSJ reports
04:16pm, Friday, 15'th May 2026
At least 20 people in Japan who took Amgen's rare disease drug have died, while 22 others developed potentially fatal liver injuries, the Wall Street Journal reported
Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new patients.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Friday, 15'th May 2026
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Amgen Inc. (AMGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:50pm, Wednesday, 13'th May 2026
Amgen Inc. (AMGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
New Study Finds These Sectors Produce the Most 100-Bagger Stocks
02:27pm, Tuesday, 12'th May 2026
On a recent episode of The Compound and Friends, hosts Josh Brown and Michael Batnick sat down with former Janus analyst Matt Ancrum to discuss his study of 100-bagger stocks.
AMGN Fairly Valued by DCF at $292
08:16am, Monday, 11'th May 2026
On May 11, 2026, we delve into the discounted cash flow (DCF) analysis for Amgen Inc (AMGN), a company that has shown a price performance of +25.8% over the pas
2 Dividend Stocks to Double Up On Right Now
01:30pm, Friday, 08'th May 2026
Amgen is handling a recent patent cliff pretty well. Merck is well prepared for its own upcoming patent cliff.
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
04:01pm, Thursday, 07'th May 2026
THOUSAND OAKS, Calif., May 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 10:00 a.m.
RPRX vs. AMGN: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 06'th May 2026
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Royalty Pharma (RPRX) and Amgen (AMGN). But which of these two stocks presents investors with the be
Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?
10:50am, Monday, 04'th May 2026
Guggenheim trimmed its price target (PT) on Amgen (NASDAQ:AMGN | AMGN Price Prediction) to $340 from $351 on Monday, May 4, while maintaining a Neutral rating.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 04'th May 2026
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
Amgen to invest additional $300 million to boost US manufacturing footprint
09:42am, Monday, 04'th May 2026
Amgen said on Monday it was investing an additional $300 million in Puerto Rico to expand its U.S. manufacturing network.
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR
09:00am, Monday, 04'th May 2026
Investment Strengthens American Manufacturing, Supply Chain Resilience and Next-Generation Technology THOUSAND OAKS, Calif., May 4, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced plans to i
AMGN DCF Analysis: Intrinsic Value $268 vs Price $330
07:30am, Monday, 04'th May 2026
On May 04, 2026, we present a DCF analysis for Amgen Inc (AMGN), a biopharmaceutical company known for its innovative therapies. The stock has experienced some
